Citius pharmaceuticals to present at the h.c. wainwright 23rd annual global investment conference september 13-15

Cranford, n.j., sept. 8, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products and stem cell therapies, today announced that it will present at the h.c.
CTXR Ratings Summary
CTXR Quant Ranking